Browse studies

Find your next paid study

31 recruiting studies matching your filters

An Open-Label, First-in-Human Phase 1/2, Dose-Escalation and Dose-Expansion/ Combination Therapy Study to Investigate Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Efficacy of SB-4826 as a Single Agent in Adult Participants With Locally Advanced or Metastatic Solid Tumors or Non-Hodgkin Lymphomas and in Combination With Rituximab in Adult Participants With Non-Hodgkin Lymphomas

The goal of this clinical trial is to learn what dose of the drug SB-4826 can be given safely in patients with solid tumors and non-Hodgkin lymphomas. This dru…

Non Hodgkin LymphomaSolid Tumor

Estimated

~$10 – $6,250

University of California, San DiegoNCT07222631

Observational

Long-term Cognitive, Neuropsychiatric and Functional Outcomes in Adults Who Have Received Chimeric Antigen-Receptor T-Cell (CAR-T) Therapy for Aggressive Lymphoma at Stanford - A Pilot Study

This study aims to assess the feasibility of performing neuropsychological testing to measure the cognitive performance of individuals following Axicabtagene c…

Non Hodgkin Lymphoma

Estimated

~$10 – $6,250

Stanford UniversityNCT05416554

Phase 1

IOMAB-ACT: A Phase Ib/II Multi-institutional Study of 131 I-Apamistamab Followed by CD19-Targeted CAR-T Cell Therapy for Patients With Relapsed or Refractory (R/R) Diffuse Large B-cell Lymphoma (DLBCL)

This study is being done to determine the safety, efficacy and tolerability of a single 50 mCi dose of 131I-Apamistamab given prior to FDA approved (commercial…

Non Hodgkin LymphomaDiffuse Large B Cell Lymphoma

Estimated

~$10 – $6,250

University of Texas Southwestern Medical CenterNCT06768905

Improving Communication With and Building a Stronger Medical Home Among Spanish-speaking Families in the Center for Cancer and Blood Disorders

This study will seek to improve communication with Spanish speaking families and patients with Cancer and Blood Disorders.

LeukemiaNon Hodgkin Lymphoma

Estimated

~$10 – $750

University of Colorado, DenverNCT05425992

Phase 1

Phase I/II Study of Tandem, Bispecific Anti-CD19 Anti-CD20 CAR-T Cells for Patients With Relapsed and/or Refractory B Cell Malignancies

This is a Phase I/II, interventional, single-arm, open-label, treatment study designed to evaluate the safety and efficacy of Interleukin-7 and Interleukin-15 …

Non Hodgkin Lymphoma (NHL)Mantle Cell Lymphoma (MCL)Chronic Lymphocytic Leukemia (CLL)+5 more

Estimated

~$10 – $6,250

Medical College of WisconsinNCT04186520

Observational

Lifestyle Intervention of Food and Exercise for Lymphoma Survivors (LIFE - L)

The purpose of this study is to investigate if a mediterranean diet and exercise program for Lymphoma patients during chemotherapy can improve treatment comple…

Non Hodgkin LymphomaHodgkin Lymphoma

Estimated

~$10 – $6,250

University of MiamiNCT05839210

SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

International registry for cancer patients evaluating the feasibility and clinical utility of an Artificial Intelligence-based precision oncology clinical tria…

Cancer, MetastaticCancerCancer of Pancreas+40 more

Estimated

~$10 – $1,050

Massive Bio, Inc.